1-3 of 3
Poonam Yakkundi
Close
Sort by
Journal Articles

Novel CD123xCD3 Bispecific Igm Antibody, Igm-2537, Potently Induces T-Cell Mediated Cytotoxicity of Acute Myeloid Leukemia Cells In Vivo and in Vitro with Minimal Cytokine Release

Gene Li, Zhongde Ye, Poonam Yakkundi, Marigold Manlusoc, Kathryn Logronio, Leyla Tahrani, Rodnie Rosete, David Bernados, Paul Hinton, Deepal Pandya, Nardeen Hanna, Jey Anantam, Maya F Kotturi, Liz Bogaert, Jiyoung Hong, Christina Tsai, Thomas Manley, Bruce A Keyt, Angus M. Sinclair, Liqin Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4177.
https://doi.org/10.1182/blood-2023-182891
Published: 2023
Journal Articles

CD123 Directed IgM Antibody-based T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release

Liqin Liu, Gene Li, Ling Wang, Poonam Yakkundi, Paul R. Hinton, Deepal Pandya, Manal Amoury, Keerthana Sekar, Chian Liu, Rodnie Rosete, Nardeen Hanna, Maya F. Kotturi, Liz Bogaert, Jiyoung Hong, Christina Tsai, Bruce A. Keyt, Angus M. Sinclair
Journal: Blood
Blood (2022) 140 (Supplement 1): 5918–5919.
https://doi.org/10.1182/blood-2022-165817
Published: 2022
Journal Articles

Igm-2644, a Novel CD38xCD3 Bispecific IgM T Cell Engager Demonstrates Potent Efficacy on Myeloma Cells with an Improved Preclinical Safety Profile

Keyu Li, Rui Yun, Min Chai, Poonam Yakkundi, Rodnie Rosete, Gene Li, Liqin Liu, Dean Ng, Paul R. Hinton, Maya F. Kotturi, Angus M. Sinclair, Stephen F. Carroll, Umesh Muchhal, Bruce A. Keyt
Journal: Blood
Blood (2022) 140 (Supplement 1): 6010–6011.
https://doi.org/10.1182/blood-2022-159205
Published: 2022